FDA appoints permanent acting heads for drug and vaccine centers amid leadership turmoil

The FDA has named acting heads of its drug and vaccine centers to permanent roles, aiming to stabilize an agency recently hit by senior leadership departures. The appointments signal continuity in regulatory leadership but do not resolve underlying political pressures. This matters for regulatory predictability in the US health sector.